Atjaunināt sīkdatņu piekrišanu

Bayesian Adaptive Design for Immunotherapy and Targeted Therapy 2023 ed. [Mīkstie vāki]

,
  • Formāts: Paperback / softback, 262 pages, height x width: 235x155 mm, 50 Illustrations, color; 8 Illustrations, black and white; XI, 262 p. 58 illus., 50 illus. in color., 1 Paperback / softback
  • Izdošanas datums: 21-Apr-2024
  • Izdevniecība: Springer Verlag, Singapore
  • ISBN-10: 9811984670
  • ISBN-13: 9789811984679
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 136,16 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 160,19 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
Bayesian Adaptive Design for Immunotherapy and Targeted Therapy 2023 ed.Palielināt
  • Formāts: Paperback / softback, 262 pages, height x width: 235x155 mm, 50 Illustrations, color; 8 Illustrations, black and white; XI, 262 p. 58 illus., 50 illus. in color., 1 Paperback / softback
  • Izdošanas datums: 21-Apr-2024
  • Izdevniecība: Springer Verlag, Singapore
  • ISBN-10: 9811984670
  • ISBN-13: 9789811984679
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9789811984679.html
Keywords:

This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.

Introduction to Adaptive Design and Delayed Outcomes.- Basics of Bayesian Statistics.- Phase I Dose-finding Design.- Phase II Design for Interim Monitoring.- Phase I-II Dose-finding Design.- Drug Combination Trial Design.- Conclusion.